Pre- and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in a mouse model

Journal of Virology

Volumn 71, Issue 4, 1997, Pages 2921-2927

  Kreil, Thomas R ^a   Eibl, Martha M ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FSME IMMUN; TICK BORNE ENCEPHALITIS VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; INFECTION PREVENTION; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TICK BORNE ENCEPHALITIS;

EID: 0030936129     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.4.2921-2927.1997     Document Type: Article

References (32)

1. Aebi, C., and U. B. Schaad. 1994. FSME-Immunglobulin - eine kritische Beurteilung der Wirksamkeit. Schweiz. Med. Wochenschr. 124:1837-1840.
2. Albrecht, P. 1968. Pathogenesis of neurotropic arbovirus infections. Curr. Top. Microbiol. Immunol. 43:44-91.
3. Barrett, A. D., and E. A. Gould. 1986. Antibody-mediated early death in vivo after infection with yellow fever virus. J. Gen. Virol. 67:2539-2542.
4. Brandriss, M. W., J. J. Schlesinger, E. E. Walsh, and M. Briselli. 1986. Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow lever and dengue 2 viruses. J. Gen. Virol. 67:229-234.
5. BVA/FRAME/RSPCA/UFAW Joint Working Group on Refinement. 1993. Removal of blood from laboratory mammals and birds. First report of the BVA/FRAME/RSPCA/UFAW Joint Working Group on Refinement. Lab. Anim. 27:1-22.
6. Camenga, D. L., N. Nathanson, and G. A. Cole. 1974. Cyclophosphamide-potentiated West Nile viral encephalitis: relative influence of cellular and humoral factors. J. Infect. Dis. 130:634-641.
7. De Madrid, A. T., and J. S. Porterfield. 1969. A simple micro-culture method for the study of group B arboviruses. Bull. W. H. O. 40:113-121.
8. Dolin, R., B. S. Graham, S. B. Greenberg, C. O. Tacket, R. B. Belshe, K. Midthun, M. L. Clements, G. J. Gorse, B. W. Horgan, R. L. Atmar, et al. 1991. The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network. Ann. Intern. Med. 114:119-127.
9. Gould, E. A., and A. Buckley. 1989. Antibody-dependent enhancement of yellow fever and Japanese encephalitis virus neurovirulence. J. Gen. Virol. 70:1605-1608.
10. Gould, E. A., A. Buckley, A. D. Barrett, and N. Cammack. 1986. Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. J. Gen. Virol. 67:591-595.
11. Halstead, S. B. 1989. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev. Infect. Dis. 11(Suppl. 4): S830-S839.
12. Heinz, F. X., R. Berger, W. Tuma, and C. Kunz. 1983. A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies. Virology 126:525-537.
13. Heinz, F. X., C. Kunz, and H. Fauma. 1980. Preparation of a highly purified vaccine against tick-borne encephalitis by continuous flow zonal ultracentrifugation. J. Med. Virol. 6:213-221.
14. Heinz, F. X., W. Tuma, and C. Kunz. 1981. Antigenic and immunogenic properties of defined physical forms of tick-borne encephalitis virus structural proteins. Infect. Immun. 33:250-257.
15. Holzmann, H., M. Kundi, K. Stiasny, J. Clement, P. McKenna, C. Kunz, and F. X. Heinz. 1996. Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis. J. Med. Virol. 48:102-107.
16. Jacobs, S. C., J. R. Stephenson, and G. W. Wilkinson. 1994. Protection elicited by a replication-defective adenovirus vector expressing the tick-borne encephalitis virus non-structural glycoprotein NS1. J. Gen. Virol. 75:2399-2402.
17. Kluger, G., A. Schöttler, K. Waldvogel, D. Nadal, W. Hinrichs, G. F. Wündisch, and M. C. Laub. 1995. Tickborne encephalitis despite specific immunoglobulin prophylaxis. Lancet 246:1502.
18. Kopecky, J., L. Grubhoffer, and E. Tomkova. 1991. Interaction of tick-borne encephalitis virus with mouse peritoneal macrophages. The effect of antiviral antibody and lectin. Acta Virol. (Prague) 35:218-225.
19. Környey, S. 1955. Zur vergleichenden Pathologie der Zeckenencephalitiden. Verh. Dtsch. Ges. Inn. Med. 61:231-235.
20. Kovac, W., and H. Moritsch. 1959. Zur Pathogenese der Infektion der Maus mit dem Virus der menschlichen Frühsommer-Meningoencephalitis. Zentralbl. Bakteriol. 174:440-456.
21. Kunz, C., R. Bosch, and H. Richter. 1987. Zur Wirksamkeit von FSME-Hyperimmunglobulin. Ellipse 10:109-111.
22. Kunz, C., F. X. Heinz, and H. Hofmann. 1980. Immunogenicity and reactogenicity of a highly purified vaccine against tick-borne encephalitis. J. Med. Virol. 6:103-109.
23. Kunz, C., H. Hofmann, M. Kundi, and K. Mayer. 1981. Zur Wirksamkeit von FSME-Immunglobulin. Wien. Klin. Wochenschr. 93:665-667.
24. Monath, T. P., and F. X. Heinz. 1996. Flaviviruses, p. 961-1034. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Virology. Lippincott-Raven Publishers, Philadelphia, Pa.
25. Montefiori, D. C., G. Pantaleo, L. M. Fink, J. T. Zhou, J. Y. Zhou, M. Bilska, G. D. Miralles, and A. S. Fauci. 1996. Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors. J. Infect. Dis. 173:60-67.
26. Niedrig, M., U. Klockmann, W. Lang, J. Roeder, S. Burk, S. Modrow, and G. Pauli. 1994. Monoclonal antibodies directed against tick-borne encephalitis virus with neutralizing activity in vivo. Acta Virol. 38:141-149.
27. Peiris, J. S., S. Gordon, J. C. Unkeless, and J. S. Porterfield. 1981. Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages. Nature 289:189-191.
28. Phillpotts, R. J., J. R. Stephenson, and J. S. Porterfield. 1985. Antibody-dependent enhancement of tick-borne encephalitis virus infectivity. J. Gen. Virol. 66:1831-1837.
29. Phillpotts, R. J., J. R. Stephenson, and J. S. Porterfield. 1987. Passive immunization of mice with monoclonal antibodies raised against tick-borne encephalitis virus. Brief report. Arch. Virol. 93:295-301.
30. Ravetch, J. V., and J. P. Kinet. 1991. Fc receptors. Annu. Rev. Immunol. 9:457-492.
31. Takeda, A., C. U. Tuazon, and F. A. Ennis. 1988. Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science 242:580-583.
32. Wengler, G., D. W. Bradley, M. S. Collett, F. X. Heinz, R. W. Schlesinger, and J. H. Strauss. 1995. Flaviviridae, p. 415-427. In F. A. Murphy, C. M. Fauquet, D. H. L. Bishop, S. A. Ghabrial, A. W. Jarvis, G. P. Martelli, M. A. Mayo, and M. D. Summers (ed.), Virus taxonomy. Classification and Nomenclature of Viruses. Sixth Report of the International Committee on Taxonomy of Viruses. Springer Verlag, Vienna, Austria.